Se and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Se (selenium) and Risperdal (risperidone). Common drug interactions include enuresis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Se and Risperdal. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Se?

Se has active ingredients of selenium. eHealthMe is studying from 5,604 Se users. Check the latest studies of Se.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.



On Aug, 06, 2026

13 people who take Se and Risperdal together, and have interactions are studied.

Se and Risperdal drug interactions.

What are the common drug interactions of Se and Risperdal, by gender? *:

female:

  1. Enuresis (repeated inability to control urination)
  2. Oedema peripheral (superficial swelling)
  3. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  4. Saliva altered (changes in saliva composition)

male:

  1. Anxiety
  2. Gastritis (inflammation of stomach)
  3. Photosensitivity reaction
  4. Poor quality sleep
  5. Insomnia (sleeplessness)
  6. Abdominal discomfort
  7. Depression
  8. Gait disturbance
  9. Live birth
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Se and Risperdal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anticonvulsant drug level below therapeutic
  2. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

10-19:

  1. Rash
  2. Seizure like phenomena (a variety of medical conditions may produce sudden episodes which have some similarities to epileptic seizures)
  3. Urinary incontinence (inability to control the flow of urine and involuntary urination)

20-29:

n/a

30-39:

n/a

40-49:

  1. Adverse reaction
  2. Cardiac flutter (abnormal heart rhythm)
  3. Haematochezia (passage of stools containing blood)
  4. Heart rate increased
  5. Insomnia (sleeplessness)
  6. Schizophrenia, paranoid type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect)
  7. Therapeutic response increased (high preventive response)
  8. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

50-59:

  1. Mastication disorder (disease of chewing food)
  2. Metastases to lymph nodes (cancer spreads to lymph node)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Nausea (feeling of having an urge to vomit)
  6. Neck pain
  7. Neuropathy peripheral (surface nerve damage)
  8. Oedema peripheral (superficial swelling)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Osteonecrosis of jaw (death of bone of jaw)

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Anxiety
  3. Weight decreased
  4. Abdominal discomfort
  5. Headache (pain in head)
  6. Live birth
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Pregnancy
  10. Suicidal ideation

What are the existing conditions these people have? *

  1. Abdominal Discomfort: 2 people, 15.38%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 15.38%
  4. Depression: 2 people, 15.38%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
  6. Constipation: 2 people, 15.38%
  7. Pain: 2 people, 15.38%
  8. Sleep Disorder: 2 people, 15.38%
  9. Agitation (state of anxiety or nervous excitement): 2 people, 15.38%
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Se and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Se and Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Se:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Se and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on selenium and risperidone (the active ingredients of Se and Risperdal, respectively), and Se and Risperdal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: